Erratum

This article refers to:

Rosiglitazone-induced immune thrombocytopenia

The publishers would like to apologise for errors which occurred in two separate published articles.

For the first article below,

Platelets, December 2006; 17(8): 591–593

Letter to the editor

Rosiglitazone-induced immune thrombocytopenia

Manfred Hauben & Muhammad Younus

Risk Management Strategy, Pfizer Inc, New York, USA

(Received 31 July 206; accepted 2 August 2006)

page 152 left column line 12, empirical Bayes geometric mixture should be empirical Bayes gamma mixture.

For the second article, the correct article title page is shown below.

Platelets, February 2007; 18(1): 56–67

Original article

Minimal regulation of platelet activity by PECAM-1

TARVINDER S. DHANJAL¹, EWAN A. ROSS², JOCELYN M. AUGER¹, OWEN J. T. MCCARTY¹, CRAIG E. HUGHES¹, YOTIS A. SENIS¹, CHRIS D. BUCKLEY², & STEVE P. WATSON¹

¹Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, The Medical School, University of Birmingham, Birmingham B15 2TT, UK and ²Rheumatology Research Group, Institute of Biomedical Research, Division of Immunity & Infection, The Medical School University of Birmingham, Birmingham B15 2TT, UK

(Received 26 April 206; revised 23 June 2006; accepted 23 June 2006)